Broadening a SARS-CoV-1–neutralizing antibody for potent SARS-CoV-2 neutralization through directed evolution
Science Signaling · 15.08.2023 · 16 (798)
DOI: 10.1126/scisignal.abk3516 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Signaling, erschienen am 15.08.2023. Verfasst von Fangzhu Zhao und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Gates Foundation, NIGMS NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) underscores the need for strategies to rapidly develop neutralizing monoclonal antibodies that can function as prophylactic and therapeutic agents and to help guide vaccine design. Here, we demonstrate that engineering approaches can be used to refocus an existing antibody that neutralizes one virus but not a related virus. Through a rapid affinity maturation strategy, we engineered CR3022, a SARS-CoV-1–neutralizing antibody, to bind to the receptor binding domain of SARS-CoV-2 with >1000-fold increased affinity. The engineered CR3022 neutralized SARS-CoV-2 and provided prophylactic protection from viral challenge in a small animal model of SARS-CoV-2 infection. Deep sequencing throughout the engineering process paired with crystallographic analysis of engineered CR3022 elucidated the molecular mechanisms by which the antibody can accommodate sequence differences in the epitopes between SARS-CoV-1 and SARS-CoV-2. This workflow provides a blueprint for the rapid broadening of neutralization of an antibody from one virus to closely related but resistant viruses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.
- IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.
- Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.
- Department of Integrative Structural and Computational Biology, Scripps Research Institute, La Jolla, CA 92037, USA.
- IAVI, New York, NY 10004, USA.
- Department of Pathology, George Washington University, Washington, DC 20052, USA.
ORCID-Profile: Fangzhu Zhao, Meng Yuan, Celina Keating, Namir Shaabani, Oliver Limbo, Collin Joyce, Jordan Woehl, Shawn Barman, Alison Burns, Xueyong Zhu, Michael Ricciardi, Linghang Peng, Deli Huang, Bryan Briney, Devin Sok, David Nemazee, John R Teijaro, Ian A Wilson, Dennis R Burton, Joseph G Jardine
Förderung
- Gates Foundation
- NIGMS NIH HHS
- NIAID NIH HHS
Zitieren
APA
Zhao, F., Yuan, M., Keating, C., Shaabani, N., Limbo, O., Joyce, C., Woehl, J., Barman, S., Burns, A., Tran, Q., Zhu, X., Ricciardi, M., Peng, L., Smith, J., Huang, D., Briney, B., Sok, D., Nemazee, D., Teijaro, J. R., …, & Jardine, J. G. (2023). Broadening a SARS-CoV-1–neutralizing antibody for potent SARS-CoV-2 neutralization through directed evolution. Science Signaling, 16(798). https://doi.org/10.1126/scisignal.abk3516
Vancouver
Zhao F, Yuan M, Keating C, Shaabani N, Limbo O, Joyce C, et al. Broadening a SARS-CoV-1–neutralizing antibody for potent SARS-CoV-2 neutralization through directed evolution. Science Signaling. 2023;16(798). doi:10.1126/scisignal.abk3516
BibTeX
@article{Zhao2023,
author = {Zhao, Fangzhu and Yuan, Meng and Keating, Celina and Shaabani, Namir and Limbo, Oliver and Joyce, Collin and Woehl, Jordan and Barman, Shawn and Burns, Alison and Tran, Quoc and Zhu, Xueyong and Ricciardi, Michael and Peng, Linghang and Smith, Jessica and Huang, Deli and Briney, Bryan and Sok, Devin and Nemazee, David and Teijaro, John R and Wilson, Ian A and Burton, Dennis R and Jardine, Joseph G},
title = {Broadening a SARS-CoV-1–neutralizing antibody for potent SARS-CoV-2 neutralization through directed evolution},
journal = {Science Signaling},
year = {2023},
volume = {16},
number = {798},
doi = {10.1126/scisignal.abk3516}
}
EUVIMED